Literature DB >> 26514362

Review of seizure outcomes after surgical resection of dysembryoplastic neuroepithelial tumors.

Phillip A Bonney1, Lillian B Boettcher1, Andrew K Conner1, Chad A Glenn1, Robert G Briggs1, Joshua A Santucci1, Michael R Bellew1, James D Battiste2, Michael E Sughrue3.   

Abstract

Dysembryoplastic neuroepithelial tumors (DNETs) are rare tumors that present with seizures in the majority of cases. We report the results of a review of seizure freedom rates following resection of these benign lesions. We searched the English literature using PubMed for articles presenting seizure freedom rates for DNETs as a unique entity. Patient demographics, tumor characteristics, and operative variables were assessed across selected studies. Twenty-nine articles were included in the analysis. The mean age at surgery across studies was a median of 18 years (interquartile range 11-25 years). The mean duration of epilepsy pre-operatively was a median 7 years (interquartile range 3-11 years). Median reported gross-total resection rate across studies was 79% (interquartile range 62-92%). Authors variously chose lesionectomy or extended lesionectomy operations within and across studies. The median seizure freedom rate was 86% (interquartile range 77-93%) with only one study reporting fewer than 60% of patients seizure free. Seizure outcomes were either reported at 1 year of follow-up or at last follow-up, which occurred at a median of 4 years (interquartile range 3-7 years). The number of seizure-free patients who discontinued anti-epileptic drugs varied widely from zero to all patients. Greater extent of resection was associated with seizure freedom in four studies.

Entities:  

Keywords:  Dysembryoplastic neuroepithelial tumor; Glioneuronal tumor; Resection; Review; Seizure; Surgery

Mesh:

Year:  2015        PMID: 26514362     DOI: 10.1007/s11060-015-1961-4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  65 in total

Review 1.  Tumors in Epilepsy.

Authors:  Mark Nowell; Anna Miserocchi; Andrew W McEvoy
Journal:  Semin Neurol       Date:  2015-06-10       Impact factor: 3.420

Review 2.  Epilepsy associated tumors: Review article.

Authors:  Marco Giulioni; Gianluca Marucci; Matteo Martinoni; Anna Federica Marliani; Francesco Toni; Fiorina Bartiromo; Lilia Volpi; Patrizia Riguzzi; Francesca Bisulli; Ilaria Naldi; Roberto Michelucci; Agostino Baruzzi; Paolo Tinuper; Guido Rubboli
Journal:  World J Clin Cases       Date:  2014-11-16       Impact factor: 1.337

3.  Dysembryoplastic neuroepithelial tumors: epileptogenicity related to histologic subtypes.

Authors:  Francine Chassoux; Elisabeth Landré; Charles Mellerio; Jacques Laschet; Bertrand Devaux; Catherine Daumas-Duport
Journal:  Clin Neurophysiol       Date:  2012-12-29       Impact factor: 3.708

4.  Various findings in surgically treated epilepsy patients with dysembryoplastic neuroepithelial tumors in comparison with those of patients with other low-grade brain tumors and other neuronal migration disorders.

Authors:  Rolf Degen; Aloys Ebner; Rainer Lahl; Stephanie Leonhardt; Heinz W Pannek; Ingrid Tuxhorn
Journal:  Epilepsia       Date:  2002-11       Impact factor: 5.864

5.  The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects.

Authors:  Cordelia Luyken; Ingmar Blümcke; Rolf Fimmers; Horst Urbach; Christian E Elger; Otmar D Wiestler; Johannes Schramm
Journal:  Epilepsia       Date:  2003-06       Impact factor: 5.864

6.  Dysembryoplastic neuroepithelial tumor. Features in 16 patients.

Authors:  A A Raymond; S F Halpin; N Alsanjari; M J Cook; N D Kitchen; D R Fish; J M Stevens; B N Harding; F Scaravilli; B Kendall
Journal:  Brain       Date:  1994-06       Impact factor: 13.501

7.  Epilepsy surgery in Neurofibromatosis Type 1.

Authors:  Carmen Barba; Thomas Jacques; Philippe Kahane; Tilman Polster; Jean Isnard; Frans S S Leijten; Cigdem Ozkara; Laura Tassi; Flavio Giordano; Maura Castagna; Alison John; Buge Oz; Caroline Salon; Nathalie Streichenberger; Judith Helen Cross; Renzo Guerrini
Journal:  Epilepsy Res       Date:  2013-04-16       Impact factor: 3.045

8.  Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases.

Authors:  C Daumas-Duport; B W Scheithauer; J P Chodkiewicz; E R Laws; C Vedrenne
Journal:  Neurosurgery       Date:  1988-11       Impact factor: 4.654

9.  Adult-onset epilepsy associated with dysembryoplastic neuroepithelial tumors.

Authors:  J G Burneo; J Tellez-Zenteno; D A Steven; N Niaz; W Hader; N Pillay; S Wiebe
Journal:  Seizure       Date:  2008-03-07       Impact factor: 3.184

10.  Dysembryoplastic neuroepithelial tumors: MR appearance.

Authors:  K K Koeller; W P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  1992 Sep-Oct       Impact factor: 3.825

View more
  10 in total

1.  Dysembryoplastic neuroepithelial tumors of childhood: Ege University experience.

Authors:  Eda Ataseven; Muhittin Özcan; Cemile Büşra Ölçülü; Elif Bolat; Yeşim Ertan; Ömer Kitiş; Hasan Tekgül; Mehmet Kantar
Journal:  Childs Nerv Syst       Date:  2022-06-06       Impact factor: 1.532

2.  Satellite lesions of DNET: implications for seizure and tumor control after resection.

Authors:  Jeyul Yang; Seung-Ki Kim; Ki Joong Kim; Jong Hee Chae; Byung Chan Lim; Kyu-Chang Wang; Sung-Hye Park; Ji Hoon Phi
Journal:  J Neurooncol       Date:  2019-05-03       Impact factor: 4.130

Review 3.  Awake surgery for hemispheric low-grade gliomas: oncological, functional and methodological differences between pediatric and adult populations.

Authors:  Gianluca Trevisi; Thomas Roujeau; Hugues Duffau
Journal:  Childs Nerv Syst       Date:  2016-09-20       Impact factor: 1.475

4.  Open surgery or laser interstitial thermal therapy for low-grade epilepsy-associated tumors of the temporal lobe: A single-institution consecutive series.

Authors:  Alexander A Hedaya; Kelsey C Hewitt; Ranliang Hu; Charles M Epstein; Robert E Gross; Daniel L Drane; Jon T Willie
Journal:  Epilepsy Behav       Date:  2022-03-23       Impact factor: 3.337

5.  Occipital dysembryoplastic neuroepithelial tumor presenting as adult-onset temporal epilepsy.

Authors:  Riddhi Patira; Cody Nathan; Sarah Zubkov; Camilo Gutierrez; Charles Munyon; Abir Mukherjee; Mercedes Jacobson
Journal:  Epilepsy Behav Case Rep       Date:  2017-09-12

Review 6.  Dysembryoplastic Neuroepithelial Tumor: A Benign but Complex Tumor of the Cerebral Cortex.

Authors:  Ji Hoon Phi; Se Hoon Kim
Journal:  Brain Tumor Res Treat       Date:  2022-07

7.  Effect of Early Surgical Intervention for Brain Tumors Associated with Epilepsy on the Improvement in Memory Performance.

Authors:  Tsukasa Hirano; Hime Suzuki; Katsuya Komatsu; Aya Kanno; Yuusuke Kimura; Rei Enatsu; Satoko Ochi; Hirofumi Ohnishi; Nobuhiro Mikuni
Journal:  Neurol Med Chir (Tokyo)       Date:  2022-04-12       Impact factor: 2.036

8.  The genomic landscape of dysembryoplastic neuroepithelial tumours and a comprehensive analysis of recurrent cases.

Authors:  Mélanie Pagès; Marie-Anne Debily; Frédéric Fina; David T W Jones; Raphael Saffroy; David Castel; Thomas Blauwblomme; Alice Métais; Marie Bourgeois; Emmanuèle Lechapt-Zalcman; Arnault Tauziède-Espariat; Felipe Andreiuolo; Fabrice Chrétien; Jacques Grill; Nathalie Boddaert; Dominique Figarella-Branger; Rameen Beroukhim; Pascale Varlet
Journal:  Neuropathol Appl Neurobiol       Date:  2022-08-09       Impact factor: 6.250

9.  Salvage gamma knife radiosurgery in the management of dysembryoplastic neuroepithelial tumors: Long-term outcome in a single-institution case series.

Authors:  Georges Sinclair; Heather Martin; Alia Shamikh; Amir Samadi; Gerald Cooray; Jiri Bartek; Yehya Al-Saffar; Mikael Svensson; Ernest Dodoo
Journal:  Surg Neurol Int       Date:  2017-08-09

10.  Clinical characteristics of low-grade tumor-related epilepsy and its predictors for surgical outcome.

Authors:  Chenmin He; Lingli Hu; Cong Chen; Zhe Zheng; Bo Jin; Yao Ding; Shuang Wang; Mei-Ping Ding; Junming Zhu; Shan Wang
Journal:  Ann Clin Transl Neurol       Date:  2021-05-31       Impact factor: 4.511

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.